Dr. Hardwicke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1001 US Highway 83 N
Childress, TX 79201Phone+1 940-937-3636Fax+1 940-937-9615
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 1988 - 1990
- Texas Tech University Health Sciences Center at LubbockResidency, Internal Medicine, 1985 - 1988
- The University of Texas Health Science Center at San AntonioClass of 1985
Certifications & Licensure
- TX State Medical License 1986 - 2026
- OK State Medical License 1988 - 1992
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 22 citationsA review of clinical experience with paclitaxel extravasations.Brad L Stanford, Fred Hardwicke
Supportive Care in Cancer. 2003-03-27 - 7 citationsPure Squamous Cell Carcinoma of the Gallbladder Masquerading as a Hepatic Mass.Abhilash Perisetti, Saikiran Raghavapuram, Benjamin Tharian, Irfan Warraich, Fred Hardwicke
Cureus. 2018-01-01 - 23 citationsRisk of Infection Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Somedeb Ball, Avash Das, Wasawat Vutthikraivit, Peggy J Edwards, Fred Hardwicke
Clinical Lymphoma, Myeloma & Leukemia. 2020-02-01
Abstracts/Posters
- Daratumumab-Related Hematological Toxicities in Patients with Multiple Myeloma: A Combined Analysis of Five Phase III Randomized Controlled TrialsFred Hardwicke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Updated Meta-Analysis to Evaluate the Incidence of Atrial Fibrillation and Major Bleeding in Patients with Hematologic Malignancies Treated with IbrutinibFred Hardwicke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Efficacy of Upfront Daratumumab Combination Regimen in Patients with Newly Diagnosed Multiple MyelomaFred Hardwicke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: